Now Is A Suitable Moment For A Long-Term Purchase Of Medical Properties Trust Inc (NYSE: MPW)

Currently, there are 598.99M common shares owned by the public and among those 587.22M shares have been available to trade.

The company’s stock has a 5-day price change of 10.33% and -4.08% over the past three months. MPW shares are trading -4.28% year to date (YTD), with the 12-month market performance down to -36.57% lower. It has a 12-month low price of $2.92 and touched a high of $10.74 over the same period. MPW has an average intraday trading volume of 24.13 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 9.33%, 24.04%, and -19.61% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Institutional ownership of Medical Properties Trust Inc (NYSE: MPW) shares accounts for 73.41% of the company’s 598.99M shares outstanding.

It has a market capitalization of $2.82B and a beta (3y monthly) value of 1.22. The earnings-per-share (ttm) stands at -$0.93. The company has a debt-to-equity ratio at 1.33. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.10% over the week and 6.34% over the month.

Analysts forecast that Medical Properties Trust Inc (MPW) will achieve an EPS of $0.08 for the current quarter, $0.14 for the next quarter and $0.54 for 2025. The lowest estimate earnings-per-share for the quarter is $0.04 while analysts give the company a high EPS estimate of $0.12. Comparatively, EPS for the current quarter was $0.05 a year ago. Earnings per share for the fiscal year are expected to increase by 163.46%, and 4.33% over the next financial year.

Looking at the support for the MPW, a number of firms have released research notes about the stock. Exane BNP Paribas stated their Outperform rating for the stock in a research note on March 01, 2024, with the firm’s price target at $6. Deutsche Bank coverage for the Medical Properties Trust Inc (MPW) stock in a research note released on January 30, 2024 offered a Sell rating with a price target of $2. KeyBanc Capital Markets was of a view on January 05, 2024 that the stock is Sector Weight, while Stifel gave the stock Hold rating on November 10, 2023, issuing a price target of $12- $4.50. Wells Fargo on their part issued Underweight rating on October 16, 2023.

Most Popular

Related Posts